Disappointment at Failure of Pfizer/Medivation’s Alzheimer’s Drug
Teva Regains Exclusivity on Merck Meds
Sanofi’s Cabazitaxel Improves Survival in Prostate Cancer Patients
75 Percent Of Drug Companies Formally Manage Investigator-Initiated Trials
Disappointment at Failure of Pfizer/Medivation’s Alzheimer’s Drug
Teva Regains Exclusivity on Merck Meds
Sanofi’s Cabazitaxel Improves Survival in Prostate Cancer Patients
75 Percent Of Drug Companies Formally Manage Investigator-Initiated Trials
Posted in Industry Stories